Dr. Kavya Harika Dendukuri

MBBS, MD (Internal Medicine), DM, Post Doctoral Fellowship in Transplant

Consultant

Hepatology

Chennai

Educational Qualifications

  • MBBS 2008, Mediciti Institute of Medical Sciences
  • MD Internal Medicine 2012, Navodaya Medical college hospital, Raichur, India
  • DM Medical Gastroenterology & Hepatology 2015, Sri Ramachandra University, Chennai- India.
  • PDF in Transplant Hepatology 2017, Global Health City, Chennai, India.
 

Experience

  • March 2017 to September 2018 Consultant Hepatologist, Global Health City, Chennai, India

Research & Publication

Posters:

  • Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies in MIDTERM ISGCON- 2014, Coimbatore. India.

Oral Presentations:

  • Presented a rare case of Hepatitis C at Singapore Hepatitis Conference- Best of EASL- May 2016.
  • Presented a case at a CME- February - 2016, Chennai, India.
  • Presented case series on Isolated Small Terminal Ileal Ulcers. Diagnostic Utility of Endoscopic Biopsies at MIDTERM ISGCON- 2014, Coimbatore
  • Presented a case of recurrent AIH in Post-transplant setting at MCLD, Jan-2017, Chennai.

Scientific Publications Published:

  • Kavya Harika Dendukuri, Shanti Vijayaraghavan. Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies. Journal of Evidence based Medicine and Health Care. Issue 30, July 27, 2015.
  • H Pavan, Joy V, Kavya Harika et al - Case Report on Malignant Hepatic EpitheloidHemangioendothelioma with Villaret syndrome- Journal of Clinical and Experimental Hepatology – September 28th 2016.
  • HRQL using SF36 (Generic Specific) in liver cirrhsosis – Indian Journal of Gastroentrology.
  • Cryptogenic cirrhosis - Mystery decoded on explant evaluation.
  • Explant liver opening a Pandora`s box.
  • Therapeutic plasma exchange as an adjuent to supportive management in ESLD patients with high MELD score > 25, awaiting Liver Transplantation. Journal of Clinical & Experimental Hepatology. 6(1); S36 July 2016
  • Combination of TACE & Sorafenib improve outcomes in BCLC stage B/C of Hepatocellular Carcinoma. A single centre Experience.
 
Copyrights © 2019 Rela Institute & Medical Centre. All Rights Reserved.
Designed & Developed by mokshamedia